PMC:7195088 / 28456-28592 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7195088","sourcedb":"PMC","sourceid":"7195088","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7195088","text":"g asymptomatic participants; (b) severity rating on a 3-point ordinal scale at day 14.\n• Comparison of remdesivir vs. hydroxychloroquine","divisions":[{"label":"label","span":{"begin":87,"end":88}}],"tracks":[{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T20","span":{"begin":70,"end":75},"obj":"Body_part"}],"attributes":[{"id":"A20","pred":"uberon_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/UBERON_0002542"},{"subj":"T20","pred":"source","obj":"LitCovid-PD-UBERON"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T153","span":{"begin":30,"end":31},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T154","span":{"begin":52,"end":55},"obj":"http://purl.obolibrary.org/obo/CLO_0001577"}],"attributes":[{"subj":"T153","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T154","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T373","span":{"begin":103,"end":113},"obj":"Chemical"},{"id":"T374","span":{"begin":118,"end":136},"obj":"Chemical"}],"attributes":[{"id":"A373","pred":"chebi_id","subj":"T373","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A374","pred":"chebi_id","subj":"T374","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"subj":"T373","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T374","pred":"source","obj":"LitCovid-PD-CHEBI"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-UBERON","color":"#93ecd4","default":true},{"id":"LitCovid-PD-CLO","color":"#ecba93"},{"id":"LitCovid-PD-CHEBI","color":"#a093ec"}]}]}}